首页> 外文会议>Organic sensors and bioelectronics X >Microfluidics and BIO-encapsulation for drug- and cell-therapy
【24h】

Microfluidics and BIO-encapsulation for drug- and cell-therapy

机译:微流控和BIO封装用于药物和细胞疗法

获取原文
获取原文并翻译 | 示例

摘要

We present the construction and the application of biocompatible micro- and nano-structures that can be administered systemically and transport in a targeted and effective way drugs, small molecules, stem cells or immune system cells. These polymeric nano-systems represent a primary goal for the treatment of a wide family of neurological/systemic disorders, as well as tumors and/or acute injuries. As natural, biocompatible, biodegradable and non-immunogenic building blocks, alginate and chitosan are been currently exploited. Ionotropic pre-gelation of the alginate core, followed by chitosan polyelectrolyte complexation, allows to encapsulate selected active molecules by means of physical entrapment and electrostatic interactions within sub-micron sized hydrogel vesicles. Here we present a microfluidic-assisted assembly method of nano- and micro-vesicles -under sterile, closed environment and gas exchange adjustable conditions, which is a critical issue, when the cargo to be uploaded is very sensitive. Polymer/polymer and polymer/drug mass ratio relationship are crucial in order to attain the optimum in terms of shuttle size and cargo concentration. By modulating polymer reticulation conditions, it become possible to control drug loading efficiency as well as drug delivery dynamics. Recent results on the application of these vesicles for the encapsulation and delivery of Inhibin-A and Decorin, proteins involved in acute kidney injury (AKI), for Renal tubular cell regeneration will be presented. Finally, the impact of these polysaccharide sub-micron vesicles on Human Immune cells and the metabolic and functional activity of cells embedded in the assembled vesicles will be presented and discussed.
机译:我们介绍了生物相容性的微结构和纳米结构的构建和应用,这些结构可以系统地进行管理并以靶向和有效的方式运输药物,小分子,干细胞或免疫系统细胞。这些聚合物纳米系统代表了广泛的神经系统/系统疾病以及肿瘤和/或急性损伤的治疗的主要目标。作为天然的,生物相容的,可生物降解的和非免疫原性的结构单元,藻酸盐和壳聚糖目前已被开发。藻酸盐核心的离子型预凝胶化,然后与壳聚糖聚电解质复合,可以通过物理捕获和静电相互作用将选定的活性分子封装在亚微米尺寸的水凝胶囊泡中。在这里,我们提出了一种在无菌,密闭环境和可调气体交换条件下,纳米和微囊泡的微流体辅助组装方法,当要上传的货物非常敏感时,这是一个关键问题。聚合物/聚合物与聚合物/药物的质量比关系对于在穿梭尺寸和货物浓度方面获得最佳效果至关重要。通过调节聚合物的网状化条件,可以控制药物装载效率以及药物输送动力学。这些囊泡用于封装和递送抑制素-A和Decorin(参与急性肾损伤(AKI)的蛋白质,用于肾小管细胞再生)的最新结果将被提出。最后,将介绍和讨论这些多糖亚微米囊泡对人免疫细胞的影响以及嵌入在组装的囊泡中的细胞的代谢和功能活性。

著录项

  • 来源
    《Organic sensors and bioelectronics X》|2017年|103640O.1-103640O.14|共14页
  • 会议地点 San Diego(US)
  • 作者单位

    CNR Institute for Microelectronics and Microsystems, SP Lecce-Monteroni, Lecce, Italy;

    Dipartimento di Matematica e Fisica 'Ennio De Giorgi', S.S. ISUFI, Universita del Salento, Via Arnesano, Lecce, Italy;

    Dipartimento di Matematica e Fisica 'Ennio De Giorgi', S.S. ISUFI, Universita del Salento, Via Arnesano, Lecce, Italy;

    CNR Institute for Microelectronics and Microsystems, SP Lecce-Monteroni, Lecce, Italy,Dipartimento di Matematica e Fisica 'Ennio De Giorgi', S.S. ISUFI, Universita del Salento, Via Arnesano, Lecce, Italy;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Polymeric vesicles; alginate; chitosan; microfluidic device; pH responsiveness; PEG engraftment; nanomedicine; hydrogel;

    机译:聚合囊泡;海藻酸盐壳聚糖微流体装置pH响应度; PEG接枝;纳米医学水凝胶;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号